by Stem Cell Network | Apr 5, 2011
Every two hours, someone is born with Rett Syndrome (RTT), a developmental disorder seen almost always in girls, but occasionally in boys. Those with the disease usually develop normally until they reach 12-18 months, at which point development stops and oftentimes is...
by Michelle Ly | Mar 24, 2011
Renal disease threatens approximately 2 million Canadians nationwide. The Kidney Foundation of Canada estimates that each day, an average of 14 Canadians learn that their kidneys have failed. Most diseases of the kidneys affect the nephrons, the functional unit of the...
by David Kent | Mar 22, 2011
I recently attended a special conference on Stem Cells, Development, and Cancer run by the American Association for Cancer Research (AACR) where Connie Eaves from the British Columbia Cancer Agency chaired a session entitled “Emerging Technologies” and said something...
by Chris Kamel | Mar 2, 2011
They’re promising, but not perfect. Induced pluripotent stem cells are perhaps one of the most studied areas of stem cell research today, as researchers work to improve their method of production, but new findings out of Canada and Finland suggests that the...
by Chris Kamel | Feb 28, 2011
We’ve talked often about induced pluripotent stem cells (iPS cells) on this blog — the transformation of adult terminally differentiated cells into stem cells that can differentiate into various lineages — mostly in the context of discoveries in mice...
by Michelle Ly | Feb 14, 2011
In previous posts, I discussed the use of cell therapy, specifically the application of allogenic or autologous hematopoietic stem cells (HSCs), as a way to repopulate blood cell lineages to normal levels post-treatment in patients suffering from certain types of...
Comments